LOUIS PHAM: Open Payments
NPI 1235897281 · UPLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,325 in 149 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $3,879 · 2025 $4,325
Food & beverage: $4,316Education: $10
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 20 | $1,014 |
| ABBVIE INC. | 23 | $640 |
| LEO Pharma Inc. | 29 | $540 |
| GENZYME CORPORATION | 8 | $429 |
| Organon LLC | 6 | $278 |
| Arcutis Biotherapeutics, Inc. | 21 | $263 |
| Galderma Laboratories, L.P. | 4 | $243 |
| Incyte Corporation | 12 | $233 |
| Amgen Inc. | 8 | $143 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
Products named: Bimzelx, SKYRIZI, ADBRY, DUPIXENT, VTAMA, Zoryve, OPZELURA, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
